Sir, To prevent irreproducible results caused by adsorption losses, inert proteins are often added to buffers used in radioimmunological determinations of peptides in order to coat the walls of the assay tubes. Such adhesion preventing substances are not always used in preparing solutions of biologically active peptides for i.v. infusion. Both saline without additions [1, 2] and saline with albumin [3] or modified polypeptide gelatins such as Polygeline [4] or Haemaccel [5] [6] [7] have been used as the vehicle. To investigate whether or not such additions are required, we compared changes in plasma endothelin-1 (ET-1) levels, blood pressure and kidney function in five healthy men during infusion of ET-1 dissolved in saline with or without the modified gelatin Gelofusine.
The study consisted of a 3 Â 30 min baseline period, a 3 Â 30 min vehicle period (Gelofusine or saline) and a 4 Â 30 min ET-1 period (ET-1 dissolved in Gelofusine or saline, infused at a rate of 2.5 ng/min/kg body weight). The study was performed in a randomized two-way crossover design, separated by an interval of 3 days. Plasma ET-1 was measured by radioimmunoassay [7] . Systemic effects were monitored by measuring mean arterial pressure (MAP). Renal effects were assessed by measuring glomerular filtration rate (GFR, inulin clearance), effective renal plasma flow (ERPF, para-amino-hippurate clearance), filtration fraction (FF, from GFR and ERPF), renal blood flow (RBF, from ERPF and haematocrit), sodium excretion rate (NaE), and renal vascular resistance (RVR, from MAP and RBF) [7] . Statistical analysis was performed by two-way ANOVA for repeated measures and the studentized Newman-Keuls test for multiple comparisons on the means of the last two 30 min collections of the baseline, vehicle and ET-1 periods.
The results are shown in Table 1 . During vehicle infusion (Gelofusine or saline), no significant changes occurred. During ET-1 infusion, plasma ET-1 levels increased significantly, but the increase was significantly larger when ET-1 was dissolved in Gelofusine. The ET-1 concentration in the infusion fluid did not differ from the expected value of 150 ng/ml (153 ± 6 ng/ml at the start, 152 ± 8 ng/ml at the end). When dissolved in saline, the ET-1 concentration at the start was significantly lower (83 ± 8 ng/ml) and dropped to still lower values at the end (38 ± 4 ng/ml). Taken together, the increases in plasma ET-1 were significantly correlated to the concentrations in the infusion fluid (Spearman rank correlation, r ¼ 0.65, P ¼ 0.04).
MAP increased during ET-1 infusion, but the increase reached significance only when Gelofusine was used as the vehicle. Likewise, GFR decreased only significantly using Gelofusine. FF increased significantly and to the same extent both with saline and Gelofusine. RBF and NaE decreased significantly and RVR increased significantly both with saline and Gelofusine, but using Gelofusine the changes were significantly larger.
In sum, the directions of the systemic and renal effects of ET-1 dissolved in Gelosine or saline were as anticipated, but the effects were significantly stronger when ET-1 was dissolved in Gelofusine. We measured ET-1 concentrations both in infusion fluid and in plasma. Although the aim of using Gelofusine is to prevent adsorption of ET-1 to tubing and syringes, theoretically Gelofusine itself might also (unintentionally) bind ET-1, in which case the use of an additive would not be of great help. Apparently, this problem does not occur, as judged by the considerably higher ET-1 concentrations in Gelofusine containing infusion fluid and the concomitantly higher ET-1 plasma concentrations and stronger effects on MAP and renal Sir, Falciparum malaria is a major public health problem in the tropical developing world including India. The spectrum of malaria may range from simple pyrexia to severe complicated forms including cerebral malaria [1] . Cardiac involvement in malaria is rare and predominantly limited to toxic myocarditis and conduction abnormalities [2, 3] . We report here a case with documented falciparum malaria and associated cardiac tamponade.
Case. A 30-year-old male presented to the emergency ward of our institute with a history of intermittent high-grade fever with chills for 10 days, icterus for 5 days, decreased urinary output and headache for 3 days. There was history of meleana for the last 2 days. On examination he was found to have blood pressure of 130/80 mmHg, he had a temperature of 100.8 F. He had pallor and icterus. He had no peripheral oedema. On abdominal examination he had hepato-splenomegaly. Cardiovascular examination did not reveal any abnormality. His laboratory reports showed haemoglobin 9.0 g/dl, TLC 7000/cumm, glucose 51 mg/dl, creatinine 4.6 mg/dl, blood urea nitrogen (BUN) 91 mg/dl, serum bilirubin 34 mg/dl, Naþ 137 mEq/l and Kþ 4.0 mEq/l. His peripheral blood film showed significant falciparum parasitaemia (5%).
Based on initial evaluation a diagnosis of acute renal failure, acute tubular necrosis secondary to falciparum malaria with hepatic insufficiency and upper GI bleed was made. The patient started on conservative management with i.v. quinine (10 mg/kg/day), i.v. pantoprazole (400 mg/day) and vitamin K (10 mg/day). On day 2 of admission, the patient developed severe pain in his abdomen associated with constipation and subsequently was diagnosed to have pancreatitis for which conservative management was instituted. The serial biochemical and haematological parameters are depicted in Table 1 . An ultrasound of the abdomen carried out on the same day showed bulky head of the pancreas and hypoechoic shadows on the pancreas. Serum amylase on the same day was 1760 U. On day 4 of admission he was noticed to have a pericardial rub. A twodimensional Echo revealed, evidence of pericardial effusion (Figure 1 ). The patient had a peak serum creatinine of 4.8 mg/dl and the patient was given 3 h of heparin-free haemodialysis. Gradually the patient's general condition started improving and his pancreatitis and oliguria resolved, and his output increased from 600 ml/24 h to >2000 ml/24 h. The serum creatinine decreased to 2.05 mg/ dl. However, pericarditis persisted and he had intermittent spikes of fever.
On day 7, the patient developed tachypnoea and restlessness and he was found to have a pulses paradoxus of 20 mmHg. Repeat two-dimensional echo was performed which revealed moderate pericardial effusion and cardiac tamponade. Urgent pericardiocentesis was done and 800 ml of haemorrhagic fluid was tapped and sent for microbiological examination. Pericardial fluid culture was sterile. The patient continued to be sick and pleuro-pericardial window was made on day 9 of admission. The patient showed gradual recovery and pericarditis improved. The pericardial fluid tested positive for Plasmodium falciparum antigen. The patient was continued on i.v. quinine and on 
